top of page

Unlock Your Mind Potential

MindMaze

A mobile application for MCI patients and anyone interested in maintaining and enhancing their cognitive abilities that combines engaging memory games and unique features to not only stimulate the cognitive functions of users but also add a touch of enjoyment to their daily exercises, creating a more memorable experience.

Mild
Cognitive Impairment

is a neurological condition defined by a slight but noticeable decline in cognitive abilities, such as memory, thinking, and reasoning, which is beyond what would be expected for a person's age. Individuals with MCI may experience difficulties with everyday tasks, yet they typically do not exhibit the severe impairment seen in dementia. MCI can often lead to Alzheimer's disease or other forms of dementia, but not everyone with MCI will develop dementia. Early detection and intervention are crucial in managing MCI and potentially slowing its progression.

nurse-with-patient-holding-hands-help-support-healthcare-advice-after-cancer-results-medic

More than 80% of Americans have limited knowledge or are unfamiliar with MCI, a condition that can be prevented or its progression slowed with early detection.

Why?

I chose to work on this project for my MFA thesis because of my personal connection to the dementia community. Having witnessed both of my grandfathers battle this disease until their passing, I saw their pain firsthand and on my mother, who tirelessly cared for them. Their struggle and my mother's efforts left a lasting impact on me, sparking a sense of responsibility to utilize my skills to aid those affected by dementia. Growing up, I faced the confusion and heartache of watching loved ones slip away, unable to comprehend why they no longer recognized me. With advancements in technology, I noticed a gap in resources specifically tailored to the needs of dementia patients. I embarked on this project with the hope of developing an application that could provide some relief and assistance to patients and their caregivers, aiming to ease the burden of this challenging journey, even if only in a small way.

Project timeline

Fall 2022

Brainstorming and learn more about this disease

In this initial phase, the focus was on understanding the complexities of Mild Cognitive Impairment (MCI). This included extensive research into the disease, its impact on patients and families, and exploring existing solutions. This foundational step helped shape the vision and direction for MindMaze.

Spring 2023

Empathize, Define, and Ideate

During this phase, recent articles and studies were reviewed to gain insights into the latest research and developments related to Mild Cognitive Impairment (MCI). A literature review was conducted to synthesize key findings, which formed the basis for defining challenges and brainstorming innovative solutions tailored to these insights.

Fall 2023

Conduct UX Research 

& Build Wireframes

The focus shifted to user experience (UX) research, which provided a deeper understanding of user behaviors and preferences. Based on this research, initial wireframes were created to map out the structure and functionality of the platform.

Spring 2024

Academic Research & Design system and Digital Assets

During this stage, academic studies guided the development of a robust design system. Digital assets, including icons, color schemes, and typography, were created to ensure consistency and accessibility across the platform.

Fall 2024

Design User Interfaces

With the design system in place, attention turned to creating intuitive user interfaces. Prototypes and early versions of the platform’s games and interactive features were developed, focusing on usability and engagement.

Spring 2025

Prototype and Exhibition

This final phase involves showcasing MindMaze through exhibitions to gather user feedback. Usability tests ensure that the platform meets the needs of its target audience. Additionally, marketing materials are prepared to promote MindMaze to a broader community.

Discover how MindMaze is making a difference in cognitive research and brain health.
Stay up to date with our latest news and developments.

bottom of page